BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36825813)

  • 21. Precise diagnosis of a hereditary spherocytosis patient with complicated hematological phenotype.
    Liang G; Lin Z; Zhang Y; Zhang Q; Zhu D; Liang X; Xie H; Wei X; Shang X
    Mol Genet Genomics; 2024 May; 299(1):57. PubMed ID: 38787432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: A rare case of pyruvate kinase deficiency and Crigler-Najjar syndrome type II with a novel pathogenic variant of
    Wu H; Wu L; Zhang Q; Zhang BF
    Front Genet; 2023; 14():1229271. PubMed ID: 37671043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative preimplantation genetic testing analysis for a Chinese family with hereditary spherocytosis caused by a novel splicing variant of
    Tian Y; Wang Y; Yang J; Gao P; Xu H; Wu Y; Li M; Chen H; Lu D; Yan H
    Front Genet; 2023; 14():1221853. PubMed ID: 37795245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel
    Fawaz N; Beshlawi I; Alqasim A; Zachariah M; Russo R; Andolfo I; Gambale A; Pathare A; Iolascon A
    Clin Case Rep; 2022 Feb; 10(2):e05315. PubMed ID: 35154711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the molecular etiology in rare congenital hemolytic anemias using next-generation sequencing with exome-based copy number variant analysis.
    Isik E; Aydinok Y; Albayrak C; Durmus B; Karakas Z; Orhan MF; Sarper N; Aydın S; Unal S; Oymak Y; Karadas N; Turedi A; Albayrak D; Tayfun F; Tugcu D; Karaman S; Tobu M; Unal E; Ozcan A; Unal S; Aksu T; Unuvar A; Bilici M; Azik F; Ay Y; Gelen SA; Zengin E; Albudak E; Eker I; Karakaya T; Cogulu O; Ozkinay F; Atik T
    Eur J Haematol; 2024 Mar; ():. PubMed ID: 38556258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Diagnosis of Pyruvate Kinase Deficiency in Undiagnosed Iranian Patients with Severe Hemolytic Anemia, using Whole Exome Sequencing.
    Mehrabi Sisakht J; Mehri M; Najmabadi H; Azarkeivan A; Neishabury M
    Arch Iran Med; 2022 Oct; 25(10):691-697. PubMed ID: 37542401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Red Blood Cell Membrane-Related Gene Variants and Clinical Risk Factors in Chinese Neonates with Hyperbilirubinemia.
    Lin F; Xu JX; Wu YH; Chen ZK; Chen MT; Ma YB; Li JD; Yang LY
    Neonatology; 2023; 120(3):371-380. PubMed ID: 37040722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report: Genetic analysis of a novel intronic inversion variant in the
    Xi B; Liu S; Zhu Y; Zhang D; Zhang Y; Liu A
    Front Genet; 2023; 14():1309040. PubMed ID: 38111681
    [No Abstract]   [Full Text] [Related]  

  • 29. Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child.
    Rieneck K; Lausen B; Clausen FB; Jønson L; Hansen AT; Dziegiel MH
    Transfus Med Hemother; 2022 Sep; 49(5):320-325. PubMed ID: 37969868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osmotic gradient ektacytometry: A tool for more than just hereditary haemolytic anaemia.
    Adam AS; Vaes M; Cotton F; Gulbis B
    Int J Lab Hematol; 2023 Apr; 45(2):e36-e38. PubMed ID: 36274577
    [No Abstract]   [Full Text] [Related]  

  • 31. Study on Management of Blood Transfusion Therapy in Patients with Hereditary Spherocytosis.
    Ma S; Tang L; Wu C; Tang H; Pu X; Niu J
    Appl Bionics Biomech; 2022; 2022():6228965. PubMed ID: 35126660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular diagnostic results of a nephropathy gene panel in patients with suspected hereditary kidney disease.
    Topak A
    Lab Med; 2024 Jan; 55(1):13-19. PubMed ID: 37078890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-step amplification refractory mutation system-PCR/high-resolution melting curve assay for carrier detection of red blood cell membranopathy caused by common SPTB mutations.
    Khongphithakskul P; Tangbubpha N; Khlangtan T; Kadegasem P; Songdej D; Sirachainan N
    Int J Lab Hematol; 2024 Apr; 46(2):375-382. PubMed ID: 37904725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.
    Al-Samkari H; van Beers EJ
    Ther Adv Hematol; 2021; 12():20406207211066070. PubMed ID: 34987744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitapivat-Associated Rib Fracture in a Hemolytic Anemia Patient.
    Abouelkheer Y; Ladel L; Boxer D; Shafique S
    Cureus; 2024 Mar; 16(3):e55658. PubMed ID: 38586665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the Development of Diagnostic Tools for Red Blood Cell-Related Diseases and Anemias.
    Kaestner L; Bianchi P
    Front Physiol; 2020; 11():387. PubMed ID: 32528298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory failure and shock in an infant with severe anemia.
    Walker SC; Ransom M; Sood S; Andrews J; Smith CM
    Clin Case Rep; 2021 Sep; 9(9):e04852. PubMed ID: 34584715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: Images from red cells, Volume II.
    Minetti G; Bianchi P; Bogdanova A; Kaestner L
    Front Physiol; 2023; 14():1252273. PubMed ID: 37565144
    [No Abstract]   [Full Text] [Related]  

  • 39. Progress in expanding newborn screening in the United States.
    Grosse SD; Cuthbert C; Gaffney M; Gaviglio A; Hinton CF; Kellar-Guenther Y; Kemper AR; McKasson S; Ojodu J; Riley C; Singh S; Sontag MK; Shapira SK
    Am J Hum Genet; 2023 Jun; 110(6):1015-1016. PubMed ID: 37267896
    [No Abstract]   [Full Text] [Related]  

  • 40. Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial.
    Srivastava A; Rangarajan S; Kavakli K; Klamroth R; Kenet G; Khoo L; You CW; Xu W; Malan N; Frenzel L; Bagot CN; Stasyshyn O; Chang CY; Poloskey S; Qiu Z; Andersson S; Mei B; Pipe SW
    Lancet Haematol; 2023 May; 10(5):e322-e332. PubMed ID: 37003278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.